Document is current
Any future updates will be listed below
-
Authors
Marchesi, Silvia
Marinello, Arianna
Ambrosini, Paolo
Cavalli, Chiara
Lo Russo, Giuseppe
Occhipinti, Mario
- License Information
-
More Information
Article History
Received: 14 April 2025
Accepted: 15 June 2025
First Online: 2 July 2025
Competing interests
: The authors declare no Competing Non-Financial Interests but the following Competing Financial Interests: Arianna Marinello declares Travel/accommodation from Daiichi Sankyo; non-financial support from MSD. Giuseppe Lo Russo declares personal fees for his advisory role, travel accommodations, speaker fees, writing fees, consultancies, honoraria, and pi for profit trials from MSD, Regeneron, Roche, Lilly, BMS, Amgen, Astra Zeneca, Johnson and Johnson, Merck, Novartis, Pierre Fabre, Bayer, Beigene, Pfizer, GSK, DAlICHi, Takeda, and Sanofi. Mario Occhipinti declares Honoraria from Astra Zeneca, BMS, MSD; Consulting or Advisory Role from Astra Zeneca, BMS, MSD, Pfizer; Travel, Accommodations, Expenses from Eli Lilly.
